These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

247 related items for PubMed ID: 3868736

  • 1. [Anti-bacterial effect of ofloxacin--in vitro and in vivo results].
    Altay G, Tulunay C.
    Mikrobiyol Bul; 1985 Oct; 19(4):183-9. PubMed ID: 3868736
    [Abstract] [Full Text] [Related]

  • 2. In vitro study of the antibacterial activity of ofloxacin against recent clinical isolates.
    Varoli O, Ferri M.
    Drugs Exp Clin Res; 1987 Oct; 13(4):209-12. PubMed ID: 3476290
    [Abstract] [Full Text] [Related]

  • 3. A comparative study of the sensitivity of bacteria of various origin to ofloxacin.
    Gubina M.
    Chemioterapia; 1987 Apr; 6(2):79-81. PubMed ID: 3474082
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Susceptibility in vitro to certain quinolines of gram-negative bacteria and gram-positive cocci causing urinary tract infections].
    Mróz E, Jankowski S, Bartelmus J, Grzybek-Hryncewicz K, Ruczkowska J, Starek J, Boratyńska M.
    Med Dosw Mikrobiol; 1993 Apr; 45(1):115-8. PubMed ID: 8231429
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Comparative studies of DL-8280 and pipemidic acid in complicated urinary tract infections by double-blind method].
    Kishi H, Nito H, Saito I, Nishimura Y, Niijima T, Ohmori H, Tanaka H, Fujita Y, Deguchi K, Ogawa N.
    Hinyokika Kiyo; 1984 Sep; 30(9):1307-55. PubMed ID: 6395684
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Newer carbapenems for urinary tract infections.
    Matsumoto T, Muratani T.
    Int J Antimicrob Agents; 2004 Sep; 24 Suppl 1():S35-8. PubMed ID: 15364304
    [Abstract] [Full Text] [Related]

  • 15. [Clinical evaluation of ofloxacin against complicated urinary tract infections].
    Nishio S, Yoshihara H.
    Hinyokika Kiyo; 1987 Sep; 33(9):1503-7. PubMed ID: 3481217
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.